Swati Banerjee
Pediatric Endocrinology · Madera, CANPI 1134197858
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 31.9% of the total. Reporting peaked in 2021 at $777 and has fallen 65.2% since, to $270 in 2022.
Across 89 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$579
- Abbott$141
- Novo Nordisk$137
- Biomarin Pharmaceutical Inc.$115
- Lilly USA, LLC$94
- Pfizer$89
- plus $661 from 17 others
What the payments were for
- Food & beverage$1,70194%
- Education$1156%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $579 |
| Abbott | 9 | $141 |
| Novo Nordisk | 7 | $137 |
| Biomarin Pharmaceutical Inc. | 3 | $115 |
| Lilly USA, LLC | 6 | $94 |
| Pfizer | 6 | $89 |
| Ipsen Biopharmaceuticals, Inc | 3 | $67 |
| Tandem Diabetes Care, Inc. | 4 | $64 |
| Vistapharm, Inc. | 3 | $64 |
| Ultragenyx Pharmaceutical Inc. | 3 | $57 |
| Dexcom, Inc. | 4 | $56 |
| Medtronic(2 entities) | 4 | $55 |
| Ascendis Pharma Endocrinology Inc | 2 | $51 |
| Insulet Corporation | 2 | $45 |
| Arbor Pharmaceuticals, Inc. | 2 | $36 |
| Lifescan, Inc. | 2 | $35 |
| BD | 1 | $31 |
| Tolmar Pharmaceuticals, Inc. | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| AstraZeneca | 1 | $16 |
| Bayer | 1 | $12 |
| Xeris Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lupron Depot$225
How this compares
$1,816 in reported general payments places this provider in the 55th percentile of 168 pediatric endocrinology providers in California.
Other pediatric endocrinology in Madera
- Jarreau Spencer ChenMadera$5K
- Omar AliMadera$5K
- Meenal MendirattaMadera$3K
- Gnanagurdasan PrakasamSacramento$805K
- Swati ElchuriVentura$210K
- Karen KleinSan Diego$195K
- Francine KaufmanLos Angeles$184K
- Lynda PolgreenOrange$167K
- Kevin KaisermanWest Covina$150K
- Amrit BhangooLong Beach$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.